Beranda › Kanker Paru Non-Sel Kecil › Florida › Ocala
Uji klinis Kanker Paru Non-Sel Kecil di Ocala, FL
10 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Ocala (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 2
- Ocala Oncology Center /ID# 273697, Ocala
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Menerima pesertaFase 3
- Local Institution - 0711, Ocala
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Florida Cancer Specialists, Ocala
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Ocala Oncology Center PL DBA Florida Cancer Affiliates - Ocala, Ocala
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Menerima pesertaFase 3
- Ocala Oncology Center PL DBA Florida Cancer Affiliates - Ocala, Ocala
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Menerima pesertaFase 3
- Clinical Study Site, Ocala
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Ocala Oncology Center PL DBA Florida Cancer Affiliates - Ocala, Ocala
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Research Site, Ocala
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Menerima pesertaFase 3
- Florida Cancer Affiliates - Ocala Oncology, Ocala
A Study of IBI363 in Subjects with Advanced Solid Malignancies
Menerima pesertaFase 2
- Ocala Oncology Center, Ocala
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Studi lain di Ocala
- Penyakit Hati Steatotik8 studi
- Obesitas7 studi
- Kelebihan Berat Badan6 studi
- Penyakit Alzheimer6 studi
- Gagal Jantung5 studi
- PPOK5 studi
- Penyakit Hati3 studi
- Nyeri Kronis3 studi
- Gangguan Kognitif Ringan3 studi
- Kanker Metastatik3 studi
- Penyakit Kardiovaskular3 studi
- Aterosklerosis3 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.